DavidRabenMD

Summary

• Dr. David Raben is a board certified radiation oncologist and holds the rank of Professor at the University of Colorado. He is listed as a "Top Doctor" by U.S. News and World Report. He received his undergraduate degree at Duke University (1981-1985) and his medical degree from Wake Forest University Health Sciences Center (1985-1990). Residency training in radiation oncology was conducted at the John Hopkins Hospital (1991-1994). He took his initial faculty position at the University of Alabama at Birmingham from 1994-1998 heading the GI tumor working group and receiving an American Cancer Society translational oncology grant to study brain tumors. Having joined the faculty at the University of Colorado in 1998, an NCI-designated Comprehensive Cancer Center he is a member of the Lung, Head & Neck Cancers Program of the University of Colorado Cancer Center. Dr Raben has extensive expertise in aerodigestive track malignancies with specific focus in head and neck cancer (HNC), Lung, Prostate and Bladder cancer and has provided contributions to the University of Colorado Cancer Center through pre-clinical and clinical investigations. Dr. Raben is an active member of the School of Medicine Admissions committee, having served over the past 15 years and currently teaches medical students in the Problem Based Learning Program.
  Having developed interests and expertise over the past 20 years in translational radiation oncology with a focus on delivery of precision drugs, Dr. Raben has explored molecular biomarkers and targets that will enhance the effects of radiation therapy in HNC. Nationally, Dr. Raben is an active participant in the NRG head and neck cancer steering committee and translational committee focusing on national, NCI approved clinical trials devoted to HNC. He serves on the SWOG Genitourinary steering comm. as well. He has over 140 peer reviewed publications and is a member of AACR, ASCO and ASTRO.